Management of nausea and vomiting in palliative care

British Journal of Hospital Medicine

Volumn 75, Issue 7, 2014, Pages 391-396

  Neoh, Karen ^a   Adkinson, Lucy ^b   Montgomery, Victoria ^c   Hurlow, Adam ^d  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c YORK TEACHING HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^d LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT;

HUMAN; NAUSEA; PALLIATIVE THERAPY; REVIEW; VOMITING;

ANTIEMETICS; HUMANS; NAUSEA; PALLIATIVE CARE; VOMITING;

EID: 84907197511     PISSN: 17508460     EISSN: 17597390     Source Type: Journal    
DOI: 10.12968/hmed.2014.75.7.391     Document Type: Review

References (18)

1. Becker DE (2010) Nausea, Vomiting, and Hiccups: A Review of Mechanisms and Treatment. Anesth Prog 57(4): 150-7.
2. Bentley A, Boyd K (2001) Use of clinical pictures in the management of nausea and vomiting: A prospective audit. Palliat Med 15: 247- 53.
3. Camilleri M, Parkman H, Mehnaz S, Abell T, Gerson L (2012) Clinical guideline: management of gastroparesis. Am J Gastroenterol 108: 18-37.
4. Clark K, Lam LT, Gibson S, Currow D (2009) The effect of ranitidine versus proton pump inhibitors on gastric secretions: A meta-analysis of randomised control trials. Anaesthesia 64: 652-7.
5. Darvill E, Dorman S, Perkins P (2013) Levomepromazine for nausea and vomiting in palliative care. Cochrane Database Syst Rev 4: CD009420 (doi: 10.1002/14651858.CD009420.pub2).
6. Ellidukuz E, Kaya D (2003) The effect of metoclopramide on QT dynamicity: double-blind, placebo-controlled, cross-over study in healthy male volunteers. Aliment Pharmacol Ther 18(1): 151-5.
7. Glare P, Pereira G, Krstjanson LJ et al (2004) Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far advanced cancer. Support Care Cancer 12: 432-40.
8. Harris DG (2010) Nausea and vomiting in advanced cancer. Br Med Bull 96(1): 175-85.
9. Hedges D, Jeppson K, Whitehead P (2003) Antipsychotic medication and seizures: A review. Drugs Today 39(7): 551-7.
10. Jackson N, Doherty J, Coulter S (2008) Neuropsychiatric Complications of commonly used palliative care drugs. Postgrad Med J 84: 121-6.
11. Joint Formulary Committee (2013) British National Formulary. 66th edition. BMJ Group and Pharmaceutical Press, London.
12. Medicines and Healthcare Products Regulatory Agency (2013) Drug safety update: Metoclopramide: risk of neurological adverse effects-restricted dose and duration of use. www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON300404 (accessed 2 April 2014).
13. Palazzo MGA, Strunin L (1984) Anaesthesia and emesis. I: Etiology. Canadian Anaesthetists' Society Journal 31(2): 178-87.
14. Perkins P, Dorman S (2009) Haloperidol for the treatment of nausea and vomiting in palliative care patients. Cochrane Database Syst Rev 2: CD006271 (doi: 10.1002/14651858. CD006271.pub2).
15. Rangwala F, Zafar Y, Abernethy A (2012) Gastrointestinal symptoms in cancer patients with advanced disease: new methodologies, insights, and a proposed approach. Curr Opin Support Palliat Care 6(1): 69-75.
16. Schuurkes J, Helsen L, Ghoos E, Eelen J, van Nueten J (1986) Stimulation of gastroduodenal motor activity: dopaminergic and cholinergic modulation. Drug Dev Res 8: 233-41.
17. Stephenson J, Davies A (2006) An assessment of aetiology-based guidelines for the management of nausea and vomiting in patients with advanced cancer. Support Care Cancer 14: 348-53.
18. Twycross R, Wilcock A (2011) Palliative Care Formulary (PCF4). 4th edn. palliativedrugs.com.